GlassScriptPhysician profile
Ankur Sunil Patel
NPI 1891189718
$4,266.29
in general payments reported to CMS, 2019-2025
10 companies · $530 in 2025
The $530 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $314 · 2021: $19.22 · 2022: $222 · 2023: $297 · 2024: $2,884 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,384 · Food and Beverage: $1,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,383.97 |
| Food and Beverage | $1,327.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,842.05 | 2020-2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $1,404.49 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Globus Medical, INC. | $372.02 | 2025 | Senza |
| Medtronic USA, INC. | $168.86 | 2020 | |
| Abbott Laboratories | $152.17 | 2023 | Proclaim |
| Mml US, INC. | $144.35 | 2023 | Reactiv8 |
| Abbvie INC. | $102.14 | 2022-2025 | |
| Nevro Corp. | $36.87 | 2022-2024 | Senza |
| Allergan, INC. | $24.12 | 2022 | |
| Spr Therapeutics, INC | $19.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.